Coronary artery disease in patients with chronic kidney disease: a brief literature review

Publish Year: 1394
نوع سند: مقاله ژورنالی
زبان: English
View: 269

This Paper With 5 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_RCM-2-4_005

تاریخ نمایه سازی: 6 اسفند 1398

Abstract:

Cardiovascular is the major cause of death in chronic kidney disease and end-stage renal disease. The cardiovascular mortality rate of patients with renal impairment is evaluated to be higher than general population. Coronary artery disease seems to be an important type of cardiovascular complication among patients with chronic kidney disease and end-stage renal disease before the renal replacement therapy. Due to the strong association between chronic kidney disease and the incidence of coronary artery disease, accurate screening, diagnosis, and management of cardiovascular complications would be essential in patients at different stages of renal dysfunction. Despite the need for the comprehensive knowledge about different aspects of coronary artery disease in patients with renal failure, there is not sufficient evidence regarding the pathophysiology, ideal diagnosis, and treatment strategies for coronary heart disease in population with chronic kidney disease. In this study, we briefly reviewed the existing literatures about the possible screening, diagnosis, and the treatment approaches of risk of coronary heart disease in patients with kidney dysfunction.

Keywords:

Authors

Mostafa Dastani

Department of cardiology, Ghaem hospital, Mashhad University of Medical Sciences, Mashhad, Iran

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Collins AJ. Cardiovascular mortality in end-stage renal disease. Am J ...
  • Lindner A, Charra B, Sherrard DJ, et al. Accelerated atherosclerosis ...
  • Joki N, Hase H, Nakamura R, et al. Onset of ...
  • Ohtake T, Kobayashi S, Moriya H, et al. High prevalence ...
  • Antman EM, Anbe DT, Armstrong PW, et al. ACC/AHA guidelines ...
  • Moe SM, Chen NX. Mechanisms of vascular calcification in chronic ...
  • Baker AR, Silva NF, Quinn DW, et al. Human epicardial ...
  • Schwarz U, Buzello M, Ritz E, et al. Morphology of ...
  • Sosnov J, Lessard D, Goldberg RJ, et al. Differential symptoms ...
  • Muntner P, Hamm LL, Kusek JW, et al. The prevalence ...
  • Stigant C, Izadnegahdar M, Levin A, et al. Outcomes after ...
  • Muntner P, He J, Hamm L, et al. Renal insufficiency ...
  • Keith DS, Nichols GA, Gullion CM, et al. Longitudinal follow-up ...
  • Uhlig K, Levey AS, Sarnak MJ. Traditional cardiac risk factors ...
  • Madore F. Uremia-related metabolic cardiac risk factors in chronic kidney ...
  • Whelton PK, Perneger TV, Brancati FL, et al. Epidemiology and ...
  • Levey AS. Controlling the epidemic of cardiovascular disease in chronic ...
  • Astor BC, Muntner P, Levin A, et al. Association of ...
  • Acharji S, Baber U, Mehran R, et al. Prognostic significance ...
  • Shroff GR, Frederick PD, Herzog CA. Renal failure and acute ...
  • Agarwal R, Andersen MJ. Prognostic importance of clinic and home ...
  • Schmidt A, Stefenelli T, Schuster E, et al. Informational contribution ...
  • Karthikeyan V, Ananthasubramaniam K. Coronary risk assessment and management options ...
  • Isbel NM, Haluska B, Johnson DW, et al. Increased targeting ...
  • Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention ...
  • Seliger SL, Weiss NS, Gillen DL, et al. HMG-CoA reductase ...
  • Fellstrom BC, Jardine AG, Schmieder RE, et al. Rosuvastatin and ...
  • Wanner C, Krane V, Marz W, et al. Atorvastatin in ...
  • Baigent C, Landray MJ, Reith C, et al. The effects ...
  • Tsai TT, Maddox TM, Roe MT, et al. Contraindicated medication ...
  • Szummer K, Lundman P, Jacobson SH, et al. Influence of ...
  • Liu JY, Birkmeyer NJ, Sanders JH, et al. Risks of ...
  • Rahmanian PB, Adams DH, Castillo JG, et al. Early and ...
  • Hemmelgarn BR, Southern D, Culleton BF, et al. Survival after ...
  • Szczech LA, Reddan DN, Owen WF, et al. Differential survival ...
  • نمایش کامل مراجع